Just mulling this over further, I think what we need to see across the next...
- 12 months: Is, a deal signed (MPS or Regional OA with up-front money), or else a new CR becomes more-or-less inevitable. Also TGA provisional application at least lodged, and awaiting approval.
- 24 months: TGA provisional approval granted, providing the ability to sell Zilosul for OA for the first time (albiet Australia only). And/or another deal.
Obviously all trials / recruitment need to be going well in the background too, plus (hopefully) exciting data from 008 can precede discussions around potential Accelerated Approval via the FDA too.
However - as a minimum - to keep the company in cash while avoiding a CR (and assuming no major events e.g. a takeover), we're going to have to see the above bulleted points met imo.
Can they achieve that? It would be amazing if they did. I have to say though, my gut feeling is that we'll need a future CR. Delighted to be wrong, and i'm a very bullish holder, but that's how I feel about it. I'm happy with what I hold, and if it takes off i'll have no regrets whatsoever - but with all of that in mind, I might keep some powder dry to add either on potential June selling, or in the back half of CY23 in case a deal hasn't arrived.
- Forums
- ASX - By Stock
- PAR
- Ann: Paradigm AGM Presentation
Ann: Paradigm AGM Presentation, page-48
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.94M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 5719 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 1200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 0.285 |
2 | 31907 | 0.280 |
3 | 20987 | 0.275 |
3 | 52259 | 0.270 |
2 | 506500 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 1200 | 1 |
0.280 | 10766 | 2 |
0.290 | 20082 | 1 |
0.300 | 2600 | 1 |
0.310 | 1789 | 1 |
Last trade - 10.04am 03/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online